| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and Department of Physiology, Warner Lambert Research Institute Morris Plains, New Jersey
Abstract
Thyropropionic acid (T0P) had no perceptible calorigenic or goiter prevention effects in rats. T0P at 400 mg/100 g in the rat diet for 2 weeks caused no significant change in serum or liver cholesterol from controls, but it did cause a 51 % inhibition of intraperitoneally injected acetate-l-C14 incorporation into liver cholesterol. In contrast, T3P in the rat diet in dilutions as low as 0.20 mg/100 g for 2 weeks, while elevating oxygen consumption only slightly above controls, produced a significant 27.2% lowering in serum cholesterol and inhibited incorporation of acetate-1-C14 into liver cholesterol 36.6%. T3P, like T0P, did not lower liver cholesterol content in this short time. T3P may play a multiple role in its effects on cholesterol metabolism in vivo.
Footnotes
1 Preliminary results pertaining to this study appeared in abstract form [Circulation XXIV (part 2): 1090, 1961].
Received May 24, 1962.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |